| [1] 李翠, 李丽. 胰岛自身抗体测定对糖尿病分型的临床意义[J]. 现代中西医结合杂志, 2013, 22(1): 85-86.
[2] 陈晓平, 王昕, 柳彬彬, 等. I 型糖尿病的临床特点和多种胰岛自体抗体检出情况[J]. 中华糖尿病杂志, 2013, 5(6): 343-346 [3] 毕永春, 胡伟, 张葵. II 型糖尿病患者 4 种胰岛自身抗体检测的临床意义[J]. 现代医学, 2011, 39(6): 647-649.
[4] BROC H, COTTSSATER A, FERNLUND P. et al. A 12 year prospective study of the relationship between is let antibodies and beta cell function at and after the diagnosis in patients with adult-onset diabetes[J]. Diabetes, 2002, 51(6): 1754-1762.
[5] 李霞, 周智广, 黄广, 等. 两种成人隐匿性自身免疫糖尿病亚型的谷氨酸脱羧酶抗体界值的探讨[J]. 中华糖尿病杂志, 2005,
13(1): 34-38.
[6] 余晓琳, 魏华, 朱立群, 等. 成人晚发性自身免疫性糖尿病自身免疫抗体的研究进展[J]. 中国慢性病预防与控制, 2005,
13(3): 144-145.
[7] KAUFMAN D L, TOBIN A J. Glutamate decarboxylases and autoimmunity in insulin-dependent diabetes[J]. Trends Pharmacol Sci, 1993, 14(4): 107-109. [8] 赵玉成. 谷氨酸脱羧酶抗体和胰岛细胞抗体测定的临床意义[J]. 青海医药杂志, 2005, 358(5): 62-63. [9] ACHENBACH P, SCHLOSSER M, WILLIAMS A J, et al. Combined testing of antibody titer and affinity improves insulin autoantibody measurement: diabetes antibody standardization program[J]. Clin Immunol, 2007, 122(1): 85-90. [10] KAWASAKI E, NAKAMURA K, KURIYA G, et al. Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes[J]. Clin Endocrinol Metab, 2010, 95(2): 707-713. [11] SEISSLER J, SONNAVILLE J, MORGENTHALER W G, et al. Immunological heterogeneity in type 1 diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease[J]. Diabetetologia, 1998, 41(8): 891897. [12] 廖春梅. 成人隐匿性自身免疫性糖尿病的临床特征分析[J]. 医学临床研究, 2013, 30(12): 2414-2417. [13] 郑方道, 张鹏, 邱明才. 2型糖尿病患者血清谷氨酸脱羧酶抗体和胰岛细胞抗体检测临床意义[J]. 中华内科杂志, 2010, 49(1): 53-54. [14] American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus[J]. Diabetes care, 2010, 33(1): S62-S69. [15] PARK Y, LEE H, KOH C S. The low prevalence of immnogenetic markers in Korean adult-onset IDDM patients[J]. Diabetes Care, 1996, 19(3): 241-245. [16] TSURUOKA A, MATSUBA T, TOYOTA T, et al. Antibodies to GAD in Japanese deabetic patients: a multicenter study[J]. Diabetes Res Clin Pract, 1995, 28(3): 191-199. [17] 李霞, 周智广, 黄干. 谷氨酸脱羧酶抗体在初诊成人T2DM患者中的阳性率及其分布特点[J]. 中华流行病学杂志, 2005, 26(10): 800-803. [18] GALE E A. Declassifying diabetes[J]. Diabetologia, 2006, 49(9): 1989-1995. [19] 周圆, 汪大望. 成人隐匿性自身免疫性糖尿病研究进展[J]. 国际内分泌代谢杂志, 2008, 28(4): 249-252. [20] 中华医学会内分泌学分会. 中国成人 2 型糖尿病预防的专家共识[J]. 中华内分泌代谢杂志, 2014, 30(4): 277-283. [21] GRAHAM K L, ROBINSON W H, STEINMAN L, et al. High-throughput methods for measuring autoan-tibodies in systemic lupus erythematosus and orther autoimmune diseases [J]. Autoimmunity, 2004, 37(4): 269-72. [22] SINGH A K, BHATIA E, DABADGHAO P. Role of islet autoimmunity in the aetiology of different clinical subtypes of diabetes mellitus in young north Indians[J]. Diabet Med, 2000, 17(4): 275-280. [23] PINHEIRO G C, SCHEINBERG M A, APARECIDA DA SILVA M, et al. Anti-cyclyc cirtrullinated peptide antibodies in advanced rheumatoid arthritis[J]. Ann Intern Med, 2003, 139(3): 234-235. [24] ARBUCKLE M R, JAMES J A, KOHLHASE, et al. Development of autoantibodies before the clinical onser of systemic lupus erythematosus[J]. Scand J Immunol, 2001, 54(1/2): 211-219. [25] 刘海英, 王露霞, 刘云锋, 等. 原发性胆汁性肝硬化特异性自身抗体的筛查和分析[J]. 中华肝脏病杂志, 2008, 16(12): 922925. [26] JIANG X H, ZHONG R Q, FAN X Y, et al, Characterization of M2 antibodies in asymptomatic Chniese population[J]. World J Gastroenterol, 2003, 9(9): 2128-2131. [27] 郭亚平, 王春光, 刘欣, 等. 健康体检人群不同性别抗核抗体随年龄分布规律探讨[J]. 中华微生物学和免疫学杂志, 2014, 34(3): 212-215. |
